Chai Discovery
13 known investors
Chai Discovery builds a computer-aided design suite using artificial intelligence to design new molecules and drugs. The platform enables pharmaceutical companies to discover and develop medicines more efficiently by learning the principles of biological structure and interaction.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
Investors · 13
Amplify PartnersMenlo Park · $500K – $5M
Avenir Growth CapitalNew York
Bain Capital VenturesBoston · $1M – $100M
DCVC (Data Collective)Palo Alto · $5M – $25M
General CatalystSan Francisco · $30M
Index VenturesSan Francisco · $540K – $10.8M
Menlo VenturesSan Francisco · $1M – $20M
Oak HC/FTStamford
Sapphire VenturesAustin · $5M – $20M
Scribble VenturesPortola Valley · $750K – $1.5M
Sequoia CapitalMenlo Park · $4.4M – $214M
Atria VenturesreportedSan Francisco · $500K – $3Mvia Chris Leiter · inferred
Dimension CapitalreportedSan Francisco · $1M – $10M
In the news
- Chai Discovery raises $400M as AI drug discovery boomsthenextweb.com · 2026
- Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma - SiliconANGLEsiliconangle.com · 2026
- Chai Discovery Raises $400M to Accelerate AI-Driven Molecular Design Platformhitconsultant.net · 2026
- Chai brews up $400M series C to fuel AI molecule models used by Lilly, Novartis and Pfizerfiercebiotech.com · 2026
- Chai Discovery Raises $400M in Series C Fundingfinsmes.com · 2026
- Chai Discovery, an A.I. Drug Start-Up, Raises $400 Million - The New York Timesnytimes.com · 2026